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Fish is a common trigger of severe, food-allergic reactions. Only a limited number of pro-
teins induce specific IgE-mediated immune reactions. The major fish allergens are the
parvalbumins. They are members of the calcium-binding EF-hand protein family character-
ized by a conserved protein structure. They represent highly cross-reactive allergens for
patients with specific IgE to conserved epitopes. These patients might experience clinical
reactions with various fish species. On the other hand, some individuals have IgE anti-
bodies directed against unique, species-specific parvalbumin epitopes, and these patients
show clinical symptoms only with certain fish species. Furthermore, different parvalbumin
isoforms and isoallergens are present in the same fish and might display variable allergenic-
ity.This was shown for salmon homologs, where only a single parvalbumin (beta-1) isoform
was identified as allergen in specific patients. In addition to the parvalbumins, several other
fish proteins, enolases, aldolases, and fish gelatin, seem to be important allergens. New
clinical and molecular insights advanced the knowledge and understanding of fish allergy
in the last years. These findings were useful for the advancement of the IgE-based diag-
nosis and also for the management of fish allergies consisting of advice and treatment of
fish-allergic patients.
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FISH ALLERGY
PREVALENCE
In human diet, fish is a valuable source of essential amino acids,
polyunsaturated fatty acids, and lipid-soluble vitamins. Although
the fish consumption in European countries is quite stable, the
global demand for fish and fish products is increasing still steadily
(1). While many literature sources indicate that allergies to fish
are on the rise, the actual prevalence is not well established as
most studies are based on self-reported food allergies (2). It is esti-
mated that up to 0.2% of the general population is affected by fish
allergy (3, 4). However, the exposure to fish is an important fac-
tor determining the reported prevalence of fish allergy. Therefore,
the prevalence of fish allergy is greater in countries with high fish
consumption and fish-processing industries (5).
CLINICAL FEATURES
Fish allergy is a pathophysiological, IgE-mediated immune
response to specific fish proteins. Patients become sensitized by
allergen exposure via the gastro-intestinal tract during ingestion,
which is the major route of sensitization, or via the respira-
tory system by fish aeroallergens or skin contact (6–9). Com-
mon clinical manifestations are oral allergy syndrome, rhinitis,
abdominal pain, diarrhea, urticaria, angioedema, asthma, and
in severe cases, even life-threatening anaphylaxis (10–12). Fish
aeroallergens can be important triggers of atopic dermatitis (13).
There are only a few clinical studies addressing minimal eliciting
doses of fish allergy. However, already low milligram amounts
of fish seem to be sufficient to trigger allergic symptoms in
sensitized patients (14). Cross-reactivity among fish species has
been commonly reported for fish allergy (11, 15, 16). This clini-
cal cross-reactivity seems to be even more pronounced between
closely related fishes. On the other hand, it has been shown
that even highly fish-sensitized patients can tolerate certain fish
species, such as tuna (17, 18). In addition, in case reports, clin-
ical monosensitivity to single fishes has been proven for sole,
swordfish, pangasius/tilapia, tuna/marlin, and more recently, for
salmon and salmonid fishes (19–26). So far, no cross-reactivity
has been shown for fish and other seafood allergens while in
some cases, a co-sensitization to both allergen sources might
occur (27).
DIAGNOSIS AND PATIENT CARE
The diagnostic procedure is based on four main pillars: the
patient’s clinical history, in vivo analysis of skin reactivity, in vitro
quantification of specific serum IgE and, in selected cases, oral
provocation challenges. A broad diversity of fishes is globally con-
sumed but only a limited number of commercial extracts are
available for skin testing. Therefore, fresh or processed fish is com-
monly used for this in vivo analysis. However, the predictive value
of skin tests is low (28). For in vitro analysis of specific IgE levels,
the ImmunoCAP system (ThermoScientific) offers a wide panel
of fish extracts. Meanwhile, two recombinant parvalbumins from
carp and cod are available for this diagnostic assay. The predic-
tive value of fish extract-specific IgE measurements is not well
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established, but a high titer of specific IgE (20 kUA/L) was reported
to predict an allergy to cod with a likelihood of 95% (29).
Other adverse reactions might be misdiagnosed as fish allergy
(30). Allergy-like symptoms occur upon ingestion of histamine-
contaminated, spoiled fish (“scombroid fish poisoning”) (31).
Also, consumption of fish contaminated with the parasite Anisakis
simplex (herring worm) provokes acute allergic manifestations
caused by IgE-mediated sensitization to Anisakis allergens (27, 32).
To avoid severe reactions, the management of fish allergy relies
on the elimination of each fish product from the diet of the sensi-
tized patient. In some cases, it has been reported that patients may
lose their sensitivity upon eliminating diet (33, 34). The therapeu-
tic desensitization to fish has been reported only for a single case
(35). The development of specific immunotherapeutics based on
hypoallergenic variants of parvalbumins, the major fish allergens,
is the focus of ongoing studies (36, 37). Research on a primary
strategy for the prevention of fish allergy is very limited. The
current recommendations of the American Academy of Allergy,
Asthma & Immunology also do not suggest a general, delayed
introduction of fish in the diet of children (38).
FISH ALLERGENS
FOOD ALLERGENS
The few foods that are responsible for causing most allergic reac-
tions are milk, eggs, peanuts, tree nuts, fish, shellfish, soy, and
wheat. They contain potent food allergens (39). Their allergenic
potency has been related to specific protein features. These aller-
gens are highly abundant in the food sources, and moreover, they
possess a high stability toward food processing and digestion (40).
The structural stability has been allocated to different protein
characteristics such as intrinsic ligand binding and intramolecular
disulfide bonds (41). Some food allergens form protein aggre-
gates of high stability. Although some food allergens are sensitive
to gastric and intestinal digestion, degradation fragments are still
recognized by specific IgE antibodies (42). Food allergens of ani-
mal origin are mainly grouped into three protein superfamilies
such as caseins, tropomyosins, and EF-hand proteins (43).
FISH PARVALBUMINS
Most fish parvalbumins belong to the beta-subtype while the
alpha-subtype is predominantly found in other organisms. Beta-
parvalbumin has first been identified as fish allergen in Baltic cod
(44). Later on, the importance of this protein as the fish panal-
lergen was confirmed for a wide range of commonly consumed
species such as salmon, carp, mackerel, tuna, and pilchard (45–49).
Parvalbumins are highly stable, low-molecular-weight proteins
(10–12 kDa), which are very common in fish muscle (5). The mus-
cle of bony fishes is composed of two tissues, the light and dark
muscle differing by their physiological function and composition
(50). The parvalbumin expression is considerably higher in light
than in dark muscle tissue (51). In contrast to most bony fishes,
pelagic fishes such as tuna have mainly dark muscles of low par-
valbumin content (48). This complies with the low allergenicity
reported for tuna which is even used in canned preparations as
matrix for food challenges (17). Overall, the parvalbumin content
differs considerably in fish species and the different amount of
parvalbumins correlates with the variable allergenicity of fishes
(52–54). It has been shown that the parvalbumin level is up to
100-times higher in carp than in mackerel or tuna muscle. In
addition, physical and chemical effects of food processing may
alter the allergenicity of fish in food preparations by parvalbumin
degradation or oligomerization which may decrease or increase
the number of IgE epitopes (55).
Parvalbumins belong to the family of EF-hand proteins. As
such, they contain specific EF-hand motifs composed of 12
residues of long loops which are involved in the binding of diva-
lent metal ions. The N-terminal EF-hand site is a non-functional
domain while the two other EF-hand motifs are binding cal-
cium and magnesium ions (56). The physiological role of muscle
parvalbumins is related to the regulation of the intracellular cal-
cium concentration during muscle relaxation (57). Upon ion
binding and ion release, the beta-parvalbumin structure is sub-
jected to a global rearrangement indicating a general flexibility
of the EF-hand domains (58). The apo-protein, which is calcium-
depleted parvalbumin, has a reduced ability to bind IgE antibodies
from fish-allergic patients (59). Consequently, these calcium-
binding protein regions were attributed to conformational B-cell
epitopes (60).
As of today, the official database of allergens contains 21 par-
valbumins from 12 fish species1 (Table 1) (61). The Allergome
database lists far more than 100 entries for fish parvalbumins and
their isoforms/isoallergens2 (62). This much higher number arises
from a compilation of homolog, potentially allergenic molecules,
in addition to proteins of proven allergenicity. Parvalbumin has
been defined as the major fish allergen as a majority of fish-allergic
patients have IgE antibodies reacting to this muscle protein (63–
65). However, the prevalence of parvalbumin-specific IgE antibod-
ies seems to vary across different patient populations. For example,
fish-allergic patients with sensitization to tropical fishes react
mostly to allergens other than parvalbumins (66, 67). Generally,
the high clinical cross-reactivity among fishes has been attributed
to cross-reacting IgE antibodies recognizing parvalbumins from
several species (68). Recently, clinical monosensitivity to salmonid
fishes has been linked to salmonid parvalbumin-specific IgE anti-
bodies suggesting that cross-reactivity among fish parvalbumins
may be restricted to these closely related fishes (23, 25).
FISH ENOLASES AND ALDOLASES
Initially, IgE reactivity to fish beta-enolase and aldolase had been
described in single fishes (69–71). In 2013, 50 kDa enolases and
40 kDa aldolases were identified as important fish allergens in cod,
salmon, and tuna (Table 1) (72). Both enzymes are abundant in
the fish muscle as they are involved in metabolic glycolysis, the
sugar degradation during physiological production of energy.
In a recent study, IgE binding to enolases and aldolases was
detected in a high number of fish-allergic patients (72). Most
of the enolase/aldolase-positive patients also had IgE antibod-
ies to parvalbumin. Both allergens were positive in the mediator
release assay using rat basophilic leukemia cells expressing the
human high-affinity IgE receptor passively sensitized with patient
sera. They were found to be sensitive to heat treatment. Their
1www.allergen.org
2www.allergome.org
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Table 1 | Entries of official fish allergens by the International Union of
Immunological Societies Allergen Nomenclature Subcommittee
database (www.allergen.org).
Order Fish Allergen name Protein
identity
Clupeiformes Clupea harengus
(Atlantic herring)
Clu h 1.0101 Parvalbumin
Clu h 1.0201
Clu h 1.0301
Sardinops sagax
(Pacific pilchard)
Sar sa 1.0101 Parvalbumin
Cypriniformes Cyprinus carpio
(common carp)
Cyp c 1.0101 Parvalbumin
Cyp c 1.0201
Gadiformes Gadus callarias
(Baltic cod)
Gad c 1.0101 Parvalbumin
Gad m 1.0101 Parvalbumin
Gad m 1.0102
Gad m 1.0201
Gadus morhua
(Atlantic cod)
Gad m 1.0202
Gad m 2.0101 Enolase
Gad m 3.0101 Aldolase
Perciformes Lates calcarifer
(barramundi)
Lat c 1.0101 Parvalbumin
Lat c 1.0201
Oreochromis
mossambicus
(tilapia)
Ore m 4.0101 Tropomyosin
Thunnus albacares
(yellowfin tuna)
Thu a 1.0101 Parvalbumin
Thu a 2.0101 Enolase
Thu a 3.0101 Aldolase
Xiphias gladius
(swordfish)
Xip g 1.0101 Parvalbumin
Pleuronectiformes Lepidorhombus
whiffiagonis
(megrim)
Lep w 1.0101 Parvalbumin
Salmoniformes Oncorhynchus keta
(Pacific salmon)
Onc k 5.0101 Vitellogenin
Oncorhynchus
mykiss (rainbow
trout)
Onc m 1.0101
Onc m 1.0201
Parvalbumin
Salmo salar (Atlantic
salmon)
Sal s 1.0101 Parvalbumin
Sal s 2.0101 Enolase
Sal s 3.0101 Aldolase
Scorpaeniformes Sebastes marinus
(redfish)
Seb m 1.0101 Parvalbumin
Seb m 1.0201
relevance as food allergens is still not well understood especially
in parvalbumin-negative patients.
FISH GELATIN
The relevance of fish gelatin as a food allergen has been contro-
versially discussed for many years (4). Fish gelatin is commonly
used in food and pharmaceutical products replacing mammalian
gelatins (73).
Originally, IgE binding to fish collagen had been shown in fish-
allergic patients (74, 75). Later, the prevalence of fish gelatin allergy
was addressed in single clinical studies (76, 77). In one study, skin
prick tests were positive in 3 of 30 cod-allergic patients, while food
challenges were positive in one of the three tested patients. Also, its
potency as a food allergen was shown in a case report of severe ana-
phylaxis upon ingestion of sweets containing several grams of fish
gelatin (78). No cross-reactivity of mammalian and fish gelatin has
been reported so far. Another risk factor of fish gelatin is a poten-
tial contamination with fish parvalbumin as it is produced from
fish as a natural source. In fact, parvalbumin traces were detected
in isinglass, a fish collagen-based food supplement (79).
OTHER IgE-REACTIVE FISH PROTEINS
In the past decades, numerous studies reported allergens different
from parvalbumin which were specified by their molecular weight
or identified by other methods. Although most studies showed IgE
reactivity to these proteins, the relevance of these potential aller-
gens was not addressed. Several allergens (63 kDa protein, further
IgE-reactive proteins) were described for cod while some were
identified as parvalbumin oligomers (80). Furthermore, allergens
were identified in swordfish (25 kDa), eel/eelpout (40 kDa), snap-
per (35–90 kDa), tuna/marlin (94–105 kDa), scad (46–50 kDa),
tropical fishes (29–54 kDa), and pangasius/tilapia (18–45 kDa)
(20–22, 64, 66, 81, 82). Potential allergens of known identity were
found in cod (aldehyde phosphate isomerase), salmon (triose-
phosphate isomerase, fructose-bis-phosphate isomerase, serum
albumin), and tuna (creatine kinase, beta-enolase) (70, 83, 84).
Two further fish allergens have been registered by the IUIS-
allergen database (Table 1). Food allergy to fish roe has been
addressed in a few studies so far. Vitellogenin, a fish yolk pro-
tein, has been identified as a food allergen in caviar from different
fishes (85, 86). In 2013, tropomyosin, a filamentous muscle pro-
tein, was purified, cloned, and identified as a fish allergen in
tilapia-sensitized patients (87). This tilapia allergen showed high
homology (88%) to the human homolog. It was suggested that it
may be involved in autoimmune reaction of inflammatory bowel
disease as a significant proportion of the patients with IgE to
tropomyosin suffered from this autoimmune disease.
ALLERGENICITY OF PARVALBUMINS
During last decades, parvalbumins, enolases, aldolases, and fish
gelatin have been identified as allergenic fish proteins. Specific
properties have been attributed to common food allergens such
as resistance toward conditions of the gastrointestinal tract and
influences by food processing conditions (88). So far, only the aller-
genicity of parvalbumins has been characterized in more detail as
to their allergenicity while consolidated findings still need to be
generated for the other allergens.
PARVALBUMINS OF THE ALPHA- AND BETA-LINEAGE
Parvalbumins have been classified into two phylogenetic lin-
eages, alpha and beta subtype. Their isoelectric points (alpha,
pI> 5.0; beta, pI< 4.5) and the other multiple characteristics of
the primary protein structure are different (89, 90). Generally,
www.frontiersin.org April 2014 | Volume 5 | Article 179 | 3
Kuehn et al. Variable allergenicity of fish parvalbumins
parvalbumins occur in various organs such as the central nervous
system and the muscles (56). In muscles, both subtypes have been
detected in amphibian tissues while only the alpha-subtype has
been reported in mammalian and avian muscles (91, 92). Car-
tilaginous fish muscles express alpha-parvalbumins whereas the
beta-homolog is found in muscle tissue of bony fishes (93). So far,
the potency as important food allergens has been shown only for
fish beta-parvalbumins. Despite their overall structural similarity
to beta-homologs, alpha-parvalbumins are generally considered as
non-allergenic proteins (43). Indeed, parvalbumins of the alpha-
lineage have been described only as frog meat allergens (94). How-
ever, IgE cross-reactivity has also been reported between homologs
from fish and frog in a population of fish-sensitized patients (95).
In 2011, chicken alpha-parvalbumin has been reported as a poultry
allergen in chicken meat allergy (96). Interestingly, IgE recognition
of both fish and avian homologs was found in one case study while
cross-reactivity was not detected in another clinical case (97, 98).
However, the sequence identity between fish parvalbumins and
homologs from mammals and birds is low (<55%) so that IgE
cross-reactivity seems to be unlikely.
Recent classification by structural, biochemical, and phyloge-
netic analysis assigned alpha-parvalbumins into a common cluster
together with higher vertebrate, including human proteins while
beta-subtypes form a separate, only remotely related cluster of par-
valbumins which might explain the variable allergenicity of both
lineages (99, 100).
FIGURE 1 | Comparison of salmon (X97824, X97825), trout
(FN544258, FN544259), and carp (P02618; 4cpv) parvalbumins.
(A) Both salmonid beta-1 parvalbumins sequences differ from their
homologs in the N-terminal third of the protein which is not involved in
calcium binding. The allergenic peptide is specifically recognized by IgE
from a patient monosensitized to salmonid fishes. Gray, identical
residues; red, variable residues. (B) Both Ribbon and surface models
show that the allergenic peptide is localized on the surface of salmon
and trout beta-1 parvalbumins. Blue, calcium-binding regions; red, IgE
epitope.
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ANTIGENIC DETERMINANTS OF PARVALBUMIN
The amino acid sequence identities of fish parvalbumins vary
substantially (55–95%) but high structural similarity has been
reported as a common protein characteristic (101). IgE-binding
epitopes were suggested to be located in highly conserved, calcium-
binding regions of the molecule. Indeed, reduced IgE binding was
found for parvalbumin mutants with single amino acid modifi-
cations in calcium-binding motifs (60). The analysis of human
B-cell epitopes has only been addressed so far in a few parvalbu-
mins namely allergens from cod, carp, mackerel, and salmon (25,
102–104).
Both linear and conformational epitopes were found in these
studies but overall, non-plausible peptide pattern was found to
define a common IgE-binding region of fish parvalbumins. It
seems that B-cell epitopes are distributed over the whole parval-
bumin primary structure. A possible explanation might be the
polyclonal B-cell response in fish-allergic patients, which is even
more stimulated by individual’s eating habits (e.g., canned, fried,
smoked fish) leading to a high variety of exposed allergen forms
such as native, modified, or degraded parvalbumins from different
species.
PARVALBUMIN ISOFORMS OF VARIABLE ALLERGENICITY
For most patients, clinical cross-reactivity among fish species
was postulated as a specific feature of fish allergy. Although sin-
gle clinical reports showed true monosensitivity to single fishes,
there was no allergen-based explanation for these observations.
Only recently, the species-specific sensitization was attributed
to the presence of IgE antibodies selectively recognizing a sin-
gle salmonid parvalbumin isoallergen (beta-1 parvalbumin) (25).
These findings may allow two important conclusions concerning
the allergenicity of parvalbumins.
First, parvalbumins from different fishes might vary by their
allergenic potential. This might be explained by the specific sen-
sitization of the individual patient, which results from the clinical
history (eating habits, age of onset of fish allergy).
Second, the allergenicity of parvalbumin isoforms/isoallergens
from the same fish might be variable, as reported for salmon
allergens. In fact, fishes express often a high number of parval-
bumins such as that reported for carp and catfish (105, 106).
These isoforms seem to play a physiological role in the fish muscle
adaptation to developmental and environmental changes. In the
same fish, parvalbumins differing by sequence microheterogeneity
(sequence identity >90%) have been reported (99). It is con-
ceivable that these highly identical isoforms might be of variable
allergenicity. For Bet v 1, the major birch pollen allergen, a number
of isoforms with different allergenic properties were isolated (107).
Several allergenic parvalbumins have been identified in commonly
consumed fish, cod (beta-1, beta-2), salmon (beta-1, beta-2), and
herring (beta-1, beta-2, beta-3) (5). During studies of monosensi-
tivity to salmonid fishes, different antigenic regions were assumed
but only a single epitope was defined as a species-specific allergy
marker (23, 25). This unique epitope was localized on a single
isoform, the beta-1 salmon parvalbumin. For a patient with doc-
umented monosensitivity to salmonid fishes, we could confirm a
single region from salmon and trout as species-specific parval-
bumin epitope (“allergenic peptide”; Figure 1). This antigenic
region was located on the parvalbumin surface and was unique
when compared with different homologs from other fish species.
The allergenic region matched with the IgE-binding epitope iden-
tified by a subsequent study using a peptide-based microarray
assay (25). Studies with further sera from patients with specific
sensitizations are required to demonstrate the existence of anti-
genic parvalbumin regions linked to specific clinical phenotypes.
A recent study showed that 9 out of 62 fish-allergic patients (15%)
experienced clinical reactions with salmonid fishes only (72). This
suggests the conclusions that the prevalence of clinically salmon-
monosensitized patients is higher than previously assumed.
CONCLUSION
During recent decades, important insights into clinical and
allergen-based features were gained for fish allergy: the variable
allergenicity among salmon parvalbumins (beta-1, beta-2) was
shown, in addition, important new fish allergens (enolase, aldolase,
fish gelatin) were identified. These findings will help to develop
new immunotherapeutic strategies, but they have also shown that
the clinical picture of fish allergy is more complex than anticipated.
New molecules need to be implemented in IgE-based routine
assays to advance patient diagnosis and advice.
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